[PERSON]
Tae‑Yon Chun
Featured in 1 tracked story · first seen
Situations
Alteogen Hybrozyme technology licensing and commercial sales
3 clusters · 5 sources · last updated
Latest: Alteogen signs up to $3.2B licensing deal with Novartis
South Korean biotechnology firm Alteogen has expanded its Hybrozyme platform through significant licensing agreements. In August 2026, the company secured an exclusive licensing deal valued at up to $365 million with a g